Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
Titel:
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
Auteur:
Popat, Uday R Mehta, Rohtesh S Bassett, Roland Chen, Julianne Valdez, Benigno C Kawedia, Jitesh Ahmed, Sairah Alousi, Amin M Anderlini, Paolo Al-Atrash, Geath Bashir, Qaiser Ciurea, Stefan O Hosing, Chitra M Im, Jin S Jones, Roy Kebriaei, Partow Khouri, Issa Marin, David Nieto, Yago Olson, Amanda Oran, Betul Parmar, Simrit Rezvani, Katayoun Qazilbash, Muzaffar H Shah, Nina Srour, Samer A Shpall, Elizabeth J Champlin, Richard E Andersson, Borje S